Literature DB >> 19129056

Association between high myopia and progression of visual field loss in primary open-angle glaucoma.

Yi-An Lee1, Yung-Feng Shih, Luke Long-Kuang Lin, Jehn-Yu Huang, Tsing-Hong Wang.   

Abstract

BACKGROUND/
PURPOSE: Taiwan has a very high prevalence rate of myopia. We retrospectively studied the influence of myopia on the progression of visual field (VF) loss in primary open-angle glaucoma (POAG) patients.
METHODS: We studied 515 POAG patients for a minimum follow-up period of 5 years. VF examination was performed with Humphrey perimeter, 30-2 SITA standard program, every 6 months. A point-wise numerical comparison was applied to judge the VF changes. Test points showing more than 1.0 dB of sensitivity loss in mean defect were identified. A location was considered to have progression if it was detected on two consecutive visits. Progression of VF loss was confirmed if three or more test points deteriorated. Multivariate logistic regression was used to evaluate the association between progression of VF loss and various risk factors.
RESULTS: There were 262 cases. Progression of VF loss occurred in 57 eyes (21.8%) during the 5-year follow-up period. Logistic regression revealed that the deterioration was associated with older age, higher mean intraocular pressure, larger vertical cup-to-disc ratio, and greater myopic refraction status. The incidence of VF loss progression was 15.1% in the group of eyes with myopia less than -3 D, 10.5% in the group with -3 D to -6 D, 34.4% in the group with -6 D to -9 D, and 38.9% in the group with myopia greater than -9 D.
CONCLUSION: POAG patients with myopia greater than -6 D had a greater progression of VF loss.

Entities:  

Mesh:

Year:  2008        PMID: 19129056     DOI: 10.1016/S0929-6646(09)60019-X

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  12 in total

Review 1.  A single gene connects stiffness in glaucoma and the vascular system.

Authors:  Teresa Borrás
Journal:  Exp Eye Res       Date:  2016-09-01       Impact factor: 3.467

2.  Association between ganglion cell complex and axial length.

Authors:  Kazunori Hirasawa; Nobuyuki Shoji
Journal:  Jpn J Ophthalmol       Date:  2013-06-08       Impact factor: 2.447

3.  Correlation between central corneal thickness and myopia.

Authors:  Michael Mimouni; Victor Flores; Yinon Shapira; Shmuel Graffi; Shmuel Levartovsky; Tzahi Sela; Gur Munzer; Igor Kaiserman
Journal:  Int Ophthalmol       Date:  2017-10-26       Impact factor: 2.031

Review 4.  Myopia and diabetes mellitus as modificatory factors of glaucomatous optic neuropathy.

Authors:  Etsuo Chihara
Journal:  Jpn J Ophthalmol       Date:  2013-08-15       Impact factor: 2.447

5.  Clinical characteristics and outcomes of cataract surgery in highly myopic Koreans.

Authors:  Sohee Jeon; Hyun Seung Kim
Journal:  Korean J Ophthalmol       Date:  2011-03-11

6.  Myopia and inflammation.

Authors:  Carl P Herbort; Marina Papadia; Piergiorgio Neri
Journal:  J Ophthalmic Vis Res       Date:  2011-10

Review 7.  Literature review and meta-analysis of translaminar pressure difference in open-angle glaucoma.

Authors:  L Siaudvytyte; I Januleviciene; A Daveckaite; A Ragauskas; L Bartusis; J Kucinoviene; B Siesky; A Harris
Journal:  Eye (Lond)       Date:  2015-07-17       Impact factor: 3.775

8.  Relationship between visual field progression and baseline refraction in primary open-angle glaucoma.

Authors:  Tomoko Naito; Keiji Yoshikawa; Shiro Mizoue; Mami Nanno; Tairo Kimura; Hirotaka Suzumura; Yuzo Umeda; Fumio Shiraga
Journal:  Clin Ophthalmol       Date:  2016-07-28

9.  Axial Myopia Is Associated with Visual Field Prognosis of Primary Open-Angle Glaucoma.

Authors:  Chen Qiu; Shaohong Qian; Xinghuai Sun; Chuandi Zhou; Fanrong Meng
Journal:  PLoS One       Date:  2015-07-27       Impact factor: 3.240

10.  Impact of Age and Myopia on the Rate of Visual Field Progression in Glaucoma Patients.

Authors:  Hae-Young Lopilly Park; Kyung Euy Hong; Chan Kee Park
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.